Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

PROSHARES TRUST (ZBIO) Shares Outstanding (Diluted Average): 2023-2024

Historic Shares Outstanding (Diluted Average) for Zenas BioPharma (ZBIO) over the last 2 years, with Dec 2024 value amounting to $13.2 million.

  • Zenas BioPharma's Shares Outstanding (Diluted Average) rose 447.69% to $42.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.2 million, marking a year-over-year increase of 447.69%. This contributed to the annual value of $13.2 million for FY2024, which is 762.01% up from last year.
  • Per Zenas BioPharma's latest filing, its Shares Outstanding (Diluted Average) stood at $13.2 million for FY2024, which was up 762.01% from $1.5 million recorded in FY2023.
  • In the past 5 years, Zenas BioPharma's Shares Outstanding (Diluted Average) registered a high of $13.2 million during FY2024, and its lowest value of $1.5 million during FY2023.
  • In the last 2 years, Zenas BioPharma's Shares Outstanding (Diluted Average) had a median value of $7.4 million in 2023 and averaged $7.4 million.
  • Data for Zenas BioPharma's Shares Outstanding (Diluted Average) shows a peak YoY skyrocketed of 762.01% (in 2024) over the last 5 years.
  • Over the past 2 years, Zenas BioPharma's Shares Outstanding (Diluted Average) (Yearly) stood at $1.5 million in 2023, then spiked by 762.01% to $13.2 million in 2024.